Neurochemical pathways involved in the protective effects of nicotine and ethanol in preventing the development of Parkinson's disease: Potential targets for the development of new therapeutic agents
Authors:
- 1 June 2008
- journal article
- review article
- Published by Elsevier in Progress in Neurobiology
- Vol. 85 (2) , 135-147
Abstract
No abstract availableKeywords
This publication has 107 references indexed in Scilit:
- Nicotinic receptors as CNS targets for Parkinson's diseaseBiochemical Pharmacology, 2007
- Neuroprotective effect of nicotine on dopaminergic neurons by anti‐inflammatory actionEuropean Journal of Neuroscience, 2007
- Proteasome inhibitor model of Parkinson's disease in mice is confounded by neurotoxicity of the ethanol vehicleMovement Disorders, 2007
- Nicotine-induced changes of glutamate and arginine in naive and chronically alcoholized rats: An in vivo microdialysis studyBrain Research, 2006
- Widespread decrease of nicotinic acetylcholine receptors in Parkinson's diseaseAnnals of Neurology, 2005
- Modulation of Nicotine but Not Ethanol Preference by the Mouse Chrna4 A529T Polymorphism.Behavioral Neuroscience, 2005
- The association of alcohol consumption with coronary heart disease mortality and cancer incidence varies by smoking historyJournal of General Internal Medicine, 2005
- Nicotine, Brain Nicotinic Receptors, and Neuropsychiatric DisordersArchives of Medical Research, 2000
- Identification of the nuclear transcription factor NFκB in rat brain after in vivo ethanol administrationFEBS Letters, 1996
- Neuropathologic Features of Parkinson's, Huntington's, and Alzheimer's DiseasesaAnnals of the New York Academy of Sciences, 1992